The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
OMVOH mirikizumab 300 mg/15 mL (20 mg/mL) concentrated injection vial for IV infusion (2023-24)
Product name
OMVOH mirikizumab 300 mg/15 mL (20 mg/mL) concentrated injection vial for IV infusion
Sponsor name
Eli Lilly Australia Pty Ltd
Year Range
2023-24